Literature DB >> 25410868

The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.

Noémie Kempf1, Viktoriia Postupalenko1, Saurabh Bora1, Pascal Didier1, Youri Arntz1, Hugues de Rocquigny1, Yves Mély2.   

Abstract

UNLABELLED: The HIV-1 Gag polyprotein precursor composed of the matrix (MA), capsid (CA), nucleocapsid (NC), and p6 domains orchestrates virus assembly via interactions between MA and the cell plasma membrane (PM) on one hand and NC and the genomic RNA on the other hand. As the Gag precursor can adopt a bent conformation, a potential interaction of the NC domain with the PM cannot be excluded during Gag assembly at the PM. To investigate the possible interaction of NC with lipid membranes in the absence of any interference from the other domains of Gag, we quantitatively characterized by fluorescence spectroscopy the binding of the mature NC protein to large unilamellar vesicles (LUVs) used as membrane models. We found that NC, either in its free form or bound to an oligonucleotide, was binding with high affinity (∼ 10(7) M(-1)) to negatively charged LUVs. The number of NC binding sites, but not the binding constant, was observed to decrease with the percentage of negatively charged lipids in the LUV composition, suggesting that NC and NC/oligonucleotide complexes were able to recruit negatively charged lipids to ensure optimal binding. However, in contrast to MA, NC did not exhibit a preference for phosphatidylinositol-(4,5)-bisphosphate. These results lead us to propose a modified Gag assembly model where the NC domain contributes to the initial binding of the bent form of Gag to the PM. IMPORTANCE: The NC protein is a highly conserved nucleic acid binding protein that plays numerous key roles in HIV-1 replication. While accumulating evidence shows that NC either as a mature protein or as a domain of the Gag precursor also interacts with host proteins, only a few data are available on the possible interaction of NC with lipid membranes. Interestingly, during HIV-1 assembly, the Gag precursor is thought to adopt a bent conformation where the NC domain may interact with the plasma membrane. In this context, we quantitatively characterized the binding of NC, as a free protein or as a complex with nucleic acids, to lipid membranes and showed that the latter constitute a binding platform for NC. Taken together, our data suggest that the NC domain may play a role in the initial binding events of Gag to the plasma membrane during HIV-1 assembly.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410868      PMCID: PMC4300737          DOI: 10.1128/JVI.02931-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  116 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Quantification of local hydration at the surface of biomolecules using dual-fluorescence labels.

Authors:  Vasyl G Pivovarenko; Oleksandr M Zamotaiev; Volodymyr V Shvadchak; Viktoriia Y Postupalenko; Andrey S Klymchenko; Yves Mély
Journal:  J Phys Chem A       Date:  2012-03-16       Impact factor: 2.781

3.  Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Authors:  Jany Chan; Robert A Dick; Volker M Vogt
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

4.  Evidence in support of RNA-mediated inhibition of phosphatidylserine-dependent HIV-1 Gag membrane binding in cells.

Authors:  Vineela Chukkapalli; Jingga Inlora; Gabrielle C Todd; Akira Ono
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

5.  Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Electrostatic binding of proteins to membranes. Theoretical predictions and experimental results with charybdotoxin and phospholipid vesicles.

Authors:  N Ben-Tal; B Honig; C Miller; S McLaughlin
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

7.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Role of myristylation in HIV-1 Gag assembly.

Authors:  Fadila Bouamr; Suzanne Scarlata; Carol Carter
Journal:  Biochemistry       Date:  2003-06-03       Impact factor: 3.162

10.  Specific implications of the HIV-1 nucleocapsid zinc fingers in the annealing of the primer binding site complementary sequences during the obligatory plus strand transfer.

Authors:  Julien Godet; Nick Ramalanjaona; Kamal K Sharma; Ludovic Richert; Hugues de Rocquigny; Jean-Luc Darlix; Guy Duportail; Yves Mély
Journal:  Nucleic Acids Res       Date:  2011-05-04       Impact factor: 16.971

View more
  13 in total

1.  Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.

Authors:  Marilia Barros; Frank Heinrich; Siddhartha A K Datta; Alan Rein; Ioannis Karageorgos; Hirsh Nanda; Mathias Lösche
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

3.  HIV-1 Nucleocapsid Mimics the Membrane Adaptor Syntenin PDZ to Gain Access to ESCRTs and Promote Virus Budding.

Authors:  Paola Sette; Sarah K O'Connor; V Siddartha Yerramilli; Vincent Dussupt; Kunio Nagashima; Kasana Chutiraka; Jaisri Lingappa; Suzanne Scarlata; Fadila Bouamr
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

Review 4.  Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly.

Authors:  Erik D Olson; Karin Musier-Forsyth
Journal:  Semin Cell Dev Biol       Date:  2018-04-01       Impact factor: 7.727

5.  Hydrodynamic and Membrane Binding Properties of Purified Rous Sarcoma Virus Gag Protein.

Authors:  Robert A Dick; Siddhartha A K Datta; Hirsh Nanda; Xianyang Fang; Yi Wen; Marilia Barros; Yun-Xing Wang; Alan Rein; Volker M Vogt
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

6.  Structural and molecular determinants of HIV-1 Gag binding to the plasma membrane.

Authors:  Jiri Vlach; Jamil S Saad
Journal:  Front Microbiol       Date:  2015-03-20       Impact factor: 5.640

7.  HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination.

Authors:  Li-Jung Ko; Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  FEBS Open Bio       Date:  2015-04-09       Impact factor: 2.693

8.  An Infectious Rous Sarcoma Virus Gag Mutant That Is Defective in Nuclear Cycling.

Authors:  Clifton L Ricaña; Marc C Johnson
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

9.  Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag.

Authors:  Melanie Friedrich; Christian Setz; Friedrich Hahn; Alina Matthaei; Kirsten Fraedrich; Pia Rauch; Petra Henklein; Maximilian Traxdorf; Torgils Fossen; Ulrich Schubert
Journal:  Viruses       Date:  2016-04-25       Impact factor: 5.048

Review 10.  On the Selective Packaging of Genomic RNA by HIV-1.

Authors:  Mauricio Comas-Garcia; Sean R Davis; Alan Rein
Journal:  Viruses       Date:  2016-09-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.